Aparna Manjrekar

Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial

Vanita Noronha, Amit Joshi, Vijay Patil et al. · Journal of Clinical Oncology · 2017 · 326 citations

A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer

Vijay Patil, Vanita Noronha, Amit Joshi et al. · Cancer · 2019 · 127 citations

Effect of Phyllanthus niruri Linn. treatment on liver, kidney and testes in CCl4 induced hepatotoxic rats.

Aparna Manjrekar, V. Jisha, Partha Pratim Bag et al. · PubMed · 2008 · 99 citations

Lipid Peroxidation, Phyllanthus Niruri Extract, Oxidative Stress +18

Phase III randomized trial comparing weekly versus three-weekly (W3W) cisplatin in patients receiving chemoradiation for locally advanced head and neck cancer.

Vanita Noronha, Amit Joshi, Vijay Patil et al. · Journal of Clinical Oncology · 2017 · 26 citations

Advanced Head, Radiation Medicine, Neck Cancer +15

Results of a randomized phase III study of nimotuzumab in combination with concurrent radiotherapy and cisplatin versus radiotherapy and cisplatin alone, in locally advanced squamous cell carcinoma of the head and neck.

Vijay Patil, Vanita Noronha, Amit Joshi et al. · Journal of Clinical Oncology · 2018 · 11 citations

Neoadjuvant Therapy, Neuro-oncology, Radiation Medicine +17